business news
news | business updates | release information
https://ingredientpharm.com/wp-content/uploads/2026/10/Safety-assessment-of-medical-cannabis-end‑products-small.jpg
497
1024
Bastian Arlt
https://ingredientpharm.com/wp-content/uploads/2025/05/logo_ingredientpharm_300x200px.webp
Bastian Arlt2026-10-01 07:34:582026-10-01 07:34:58Safety assessment of medical cannabis end‑products
https://ingredientpharm.com/wp-content/uploads/2026/02/starter-Core-Selection-small.jpg
241
531
Bastian Arlt
https://ingredientpharm.com/wp-content/uploads/2025/05/logo_ingredientpharm_300x200px.webp
Bastian Arlt2026-09-15 14:47:382026-09-15 14:47:38The appropriate starter core selection for pellet-based oral drug delivery
https://ingredientpharm.com/wp-content/uploads/2026/02/How-do-Experts-See-HyPearls-small.jpg
376
598
Bastian Arlt
https://ingredientpharm.com/wp-content/uploads/2025/05/logo_ingredientpharm_300x200px.webp
Bastian Arlt2026-09-15 14:35:462026-09-15 14:35:46How Do Experts See HyPearls
https://ingredientpharm.com/wp-content/uploads/2026/06/Challenges-in-the-Oral-Administration-of-.jpg
500
1012
Bastian Arlt
https://ingredientpharm.com/wp-content/uploads/2025/05/logo_ingredientpharm_300x200px.webp
Bastian Arlt2026-09-15 14:08:442026-09-15 14:08:44Challenges in the Oral Administration of Gastro-Resistant Formulations
https://ingredientpharm.com/wp-content/uploads/2026/09/Comparison-CBD-Powder-vs.-Oil-release-profile.png
621
886
Bastian Arlt
https://ingredientpharm.com/wp-content/uploads/2025/05/logo_ingredientpharm_300x200px.webp
Bastian Arlt2026-09-09 15:32:402026-09-25 13:57:59CBD Release Profile: Granule vs. Oil